Funding opportunities

Home  >>  Funding opportunities

IMI2 (innovative Medicine Initiative) – Call 14

Type H2020 – Research and Innovation Actions (RIA) Call ID: H2020-JTI-IMI2-2018-14
Eligibility Application as a consortium
Main Features Topic 1: Targeted immune intervention for the management of non-response and relapse

Topic 2: Non-invasive clinical molecular imaging of immune cells

Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

Topic 4: Centre of excellence – remote decentralised clinical trials

Submission Deadline Stage 1 submission deadline: 14 June 2018

Stage 2 submission deadline: 11 December 2018

Link to call document https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-14

http://www.imi.europa.eu/apply-funding/call-documents/imi2-call-documents

http://www.imi.europa.eu/sites/default/files/uploads/documents/apply-for-funding/call-documents/imi2/IMI2%20CALL%2014%20TOPICS%20TEXT_EN.PDF

https://goo.gl/dZuGDe

Related Events IMI2 – Call 14 webinars: http://www.imi.europa.eu/news-events/events/imi2-call-14-webinars

Eurostars

Type H2020-Eureka
Eligibility SMEs from Germany

International collaboration with Hungary for the development of marketable products or services in the fields of biotechnology, process engineering and ICT

Max 300.000€ for 3 years

Main Features For a project that will develop new products, processes or services
Funding For 36 months; 50% funding rate
Submission Deadline 30.05.2018
Link to call document https://www.bmbf.de/foerderungen/bekanntmachung-1645.html

https://foerderportal.bund.de/easy/easy_index.php?auswahl=easy_formulare&formularschrank=bmbf

http://www.eureka.dlr.de/de/164.php

Related Events

Merck Research Grant

Type In celebrating the 350th anniversary of Merck
Eligibility For worldwide researchers
Main Features Research grants to stimulate innovative research in challenging areas of future importance: health lives / drug discovery; materials & solutions; life reimagines / synthetic biology; Digitalisation / computing
Funding €350,000/year for 3 years
Submission Deadline 15.08.2018
Link to call document https://www.merckgroup.com/en/research/open-innovation/350anniversaryactivities/researchgrants.html

Innovationsgutscheine

Type Förderprogramm des Landes Baden-Württemberg
Eligibility Start-ups: max 5 years from founding, with headquarters in Baden-Württemberg, max 100 employees and max total assets of 20 million
Main Features Innovative projects in sustainable mobility, environmental technology, renewable energy and resource efficiency, Health Economics, Life Sciences, ICT, Green IT and Smart Products
Funding €20,000 max (funding rate of 50%), 10 months
Submission Deadline Rolling application
Submission One step application
Link to call document https://wm.baden-wuerttemberg.de/de/innovation/innovationsgutscheine/innovationsgutschein-hightech-start-up/
Contact Tabea Dick – Modellvorhaben Innovationsgutscheine (Stuttgart), 0711/123-2615 tabea.dick@wm.bwl.de

KMU-innovativ: Biotechnologie – BioChance

Type Biotechnologie-Förderprogramm des BMBF
Eligibility SMEs (as single applicant or in cooperation with universities, research institutes or other enterprises)
Main Features For start-up and SMEs that are active in modern biotechnology or want to expand their range of activities into biotechnology

Promote bioeconomic projects and all branches of biotechnology, including the development of therapeutics, diagnostics and vaccines.

Funding 50% funding rate, max 3 years project
Submission Deadline Every year 15th of April and 15Th of October
Submission Two-steps application
Link to call document https://wm.baden-wuerttemberg.de/de/innovation/innovationsgutscheine/innovationsgutschein-hightech-start-up/

https://www.ptj.de/lw_resource/datapool/systemfiles/cbox/2163/live/lw_file/pr-C3-A4sentatio-kmu-i_04_2017.pdf

Contact Projektträger Jülich (PtJ), Dr. Eleonore Glitz Tel.: 02461 / 61-3622 E-Mail: e.glitz@fz-juelich.de

KMU-innovativ: Medizintechnik

Type Biotechnologie-Förderprogramm des BMBF
Eligibility SMEs or medium-sized companies as single applicant or in a joint project
Main Features Collective exploitation of a medical technology system

Basic research for a later product development

Value-chain development

Funding 25-50% funding rate, max 3 years project
Submission Deadline Every year 15th of April and 15Th of October
Submission Two-steps application
Link to call document https://www.gesundheitsforschung-bmbf.de/files/BMBF_KMUi-Medizintechnik_Broschur_barrierefrei.pdf
Contact VDI Technologiezentrum GmbH Projektträger Gesundheitswirtschaft, kmui-medtech@vdi.de, 030-275950641, 030-275950659

SME Instrument

Type H2020
Eligibility single SME or a consortium of SMEs
Main Features ·        ground-breaking concepts that could shape new markets

·        phase 1 is a feasibility study (optional)

·        phase 2 development of business concept further into a market-ready product (TRL 6)

Funding 70% funding rate
Submission Deadline Multiple cut-off / year

Phase 1: 03.05.2018; 05.09.2018; 07.11.2018

Phase 2: 23.05.2018 and 10.10.2018

Submission Phase 1 – €50.000 lump sum (optional; 6 months)

Phase 2 – €0.5 million and €2.5 million (12-24 months)

Link to call document http://ec.europa.eu/research/participants/data/ref/h2020/wp/2018-2020/main/h2020-wp1820-eic_en.pdf
Contact National Contact Point: http://www.nks-kmu.de/service-ansprechpartner.php

Fast track to Innovation

Type H2020
Eligibility Consortia with three to five entities from at least three different EU Member States

Allocation of at least 60% of the overall budget to consortium partner(s) from industry; or a minimum of 2 industry partners out of a consortium of 3 or 4; or a minimum of 3 industry partners out of a consortium of 5

Main Features FTI accelerates the market uptake of ground-breaking innovations by providing funding in an open, accessible scheme that nurtures ideas from consortia of innovators of all types and sizes from across Europe
Funding funding rate: 70% for for-profit entities; 100% for not-for-profit entities
Submission Deadline 31.05.2018 and 23.10.2018
Submission One step application. Max €3 millions
Link to call document http://ec.europa.eu/research/participants/data/ref/h2020/wp/2018-2020/main/h2020-wp1820-eic_en.pdf
Contact National Contact Point: http://www.nks-kmu.de/service-ansprechpartner.php

Cross4health project

Type Project funded by H2020-Innosup call
Eligibility At least 2 legal SMEs, additional SMEs or other legal entities can also join the team

At least 2 countries in the consortium

Main Features Three key challenges are proposed:

Provide safe remote care

Optimized care environment of hospitals and other care institutions

Faster process from sample to result

Funding € 60.000 (9 months)
Submission Deadline 16.05.2018
Link to call document http://www.cross4health.eu/opencall.html

Eurostars

Type H2020-Eureka
Eligibility SME as lead

Budget assigned to SMEs must be equal at least 50.00 % of the total project budget

International collaboration: at least 2 different partners from 2 different Eurostars countries.

Main Features For a project that will develop new products, processes or services
Funding For 36 months; 50% funding rate
Submission Deadline 13.09.2018
Link to call document https://www.eurostars-eureka.eu/start-your-eurostars-project

http://eurostars.dlr.de/

https://www.eurostars-eureka.eu/countries/germany

More funding opportunities: http://foerderdatenbank.de/